Personalized organ-preserving approach to the treatment of early esophagogastric junction cancer: a case repor
Open Access
- 11 July 2026
- journal article
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 25 (3) , 127-136
Abstract
Background. Early esophagogastric junction cancer with submucosal invasion (pT1b) has traditionally been an indication for radical esophagectomy due to the risk of lymphatic metastasis. However, accumulating evidence points to heterogeneity in the biological behavior of these tumors: in patients with a favorable histological profile (low-grade differentiation, absence of lymphovascular and perineural invasion), the rate of metastasis may be comparable to postoperative mortality associated with esophagectomy. A personalized organ‑preserving approach including endoscopic submucosal dissection (ESD) and intraoperative indocyanine green (ICG) navigation of sentinel lymph nodes may potentially avoid debilitating surgery in selected patients. Nevertheless, the safety and efficacy of this strategy for deep submucosal invasion (sm2, depth >500 μm) remain controversial. Case presentation. A 63‑year‑old patient with early esophagogastric junction cancer (cT1aN0M0, Siewert type II ) underwent combined modality treatment including laparoscopic ICG navigation with removal of two sentinel lymph nodes along the lesser curvature of the stomach (frozen‑section analysis showed no metastases) and simultaneous endoscopic submucosal dissection (ESD). Final histopathological examination of the resected specimen revealed a well‑differentiated adenocarcinoma pT1b sm2 (>500 μm) with no lymphovascular or perineural invasion, a negative vertical margin, but scattered tumor cells in the coagulated horizontal margin. Two months later, residual tumor was diagnosed and repeat ESD achieved R0 resection. Seventeen months after the primary procedure, a solitary lymphogenous metastasis was detected along the left gastric artery. Laparoscopic selective lymphadenectomy and adjuvant polychemotherapy (8 cycles of XELOX) were performed. No signs of recurrence were observed 4.5 years after repeat ESD and 3 years after lymphadenectomy. Conclusion. This case report demonstrates that a personalized organ‑preserving approach (ESD with ICG‑guided sentinel lymph node navigation) can be implemented in carefully selected patients with early high‑risk esophagogastric junction cancer (pT1b sm2) and favorable histological characteristics (G1–2, L0, V0). Strict multimodal surveillance enables timely detection of oligometastatic progression and selective lymphadenectomy, thereby avoiding esophagectomy and preserving quality of life. Further data accumulation is needed to refine patient selection criteria and optimize follow‑up protocols.Keywords
This publication has 21 references indexed in Scilit:
- Endoscopic Ultrasound in Cancer StagingGastrointestinal Endoscopy Clinics of North America, 2023
- American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendationsGastrointestinal Endoscopy, 2023
- Endoscopic submucosal dissection versus endoscopic mucosal resection for early esophageal adenocarcinomaClinics and Research in Hepatology and Gastroenterology, 2023
- Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinomaGastrointestinal Endoscopy, 2022
- Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett’s EsophagusDigestive Diseases and Sciences, 2020
- Therapeutic Options for Early Cancer of the Esophagogastric JunctionCirugía Española (English Edition), 2019
- Management of Early Stage Gastric and Gastroesophageal Junction MalignanciesSurgical Clinics of North America, 2019
- Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in JapanGastrointestinal Endoscopy, 2019
- The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patternsSurgical Endoscopy, 2014
- Efficacy, Safety, and Long-term Results of Endoscopic Treatment for Early Stage Adenocarcinoma of the Esophagus With Low-risk sm1 InvasionClinical Gastroenterology and Hepatology, 2013